Abiraterone prostate cancer drug molecule

Abiraterone prostate cancer drug molecule

C001/1306 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.5MB

Downloadable file size: 330.2KB

Price image Pricing

Please login to use the price calculator


Caption: Abiraterone. Molecular model of the drug abiraterone (C24.H31.N.O), which is being tested for use in the treatment of prostate cancer. Atoms are colour-coded spheres (carbon: green, nitrogen: blue, hydrogen: white, oxygen: red). The prostate is a gland beneath the bladder in men which produces a fluid that forms part of the semen. Elevated blood levels of testosterone may increase the risk of prostate cancer. Abiraterone blocks the production of testosterone by inhibiting an enzyme involved in its formation. This leads to the death of the cancerous cells.

Release details: Model release not required. Property release not required.

Keywords: 1, abiraterone, anti-cancer, atom, atoms, biochemical, biochemistry, biological, biology, block, blocking, cancer, chemical, chemistry, compound, compounds, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, drug, drugs, enzyme inhibitor, healthcare, inhibitory, medical, medication, medicine, molecular, molecular model, molecule, oncology, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, prostate cancer, single, space fill, space filled, space-fill, space-filled, spacefill, spacefilled, structural, structure, testosterone, testosterone blocker, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.